24. Bento L, Diaz-Lopez A, Barranco G, et al. Newprognosis score including absolute lymphocytes/monocytes ratio and beta2 microglobulin in patients with diffuse large B cell lymphoma (DLBCL) treated with R-CHOP: Spanis...
NCCN：美国国立综合癌症网络 MMR：肿块最大径/胸腔最大径 MTR：肿块最大径/胸腔T5/6水平横径 晚期（III-IV期）霍奇金淋巴瘤 国际预后评分 (IPS）III-IV期霍奇金淋巴瘤国际预后评分（International Prognostic Score，IPS），有助于判断晚期HL的长期生存和指导治疗，包括7个不良预后因素，每增加一个不良预后因素，...
On the other hand, patients with a low IPI score may have a better prognosis and could potentially benefit fromless intensive treatments. 对于原发性皮肤弥漫大细胞B细胞淋巴瘤,腿部型,IPI评分可用于评估疾病进展的风险并指导治疗决策。高IPI评分的患者被认为具有更差的预后,并可能需要更具侵袭性的治疗,如...
Previous studies have focused on adding clinical or biologic prognostic factor(s) to the original model or regrouping the original IPI score (R-IPI; Sehn, Blood, 2007). We, therefore, built anew a modern IPI based solely on clinical factors available in the real world ...
PD-1 INHIBITOR PLUS CHEMOTHERAPY IN RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) WITH AGGRESSIVE BULKY DISEASE median age 30 years (range: 16 ‐ 45), 52% female (15/29), median 3 lines of prior therapy (range: 2 ‐ 6), median 6 cycles of rituximab‐containing ...
The ages, BMI, gender, and aaIPI scores for the patients in the pooled analysis are shown in Table 1(b). High aaIPI score, age older than 60 years, and male gender were associated with a shorter PFS; the median PFS was 118 months for patients with low aaIPI scores versus 41 months...
To better recognize disease-attributable high-risk patients, we developed a new EMZL prognosis score chiefly based on patient's disease characteristics. METHODS: The revised (R)-MALT-IPI was developed using a retrospective data set of 405 EMZL patients treated at the University of Miami (UM) ...
(range 19–80 years), which was similar to three other recent studies of Chinese DLBCL patients14,15,16, but much younger than those reported for DLBCL populations in the Western countries17,18. Based on the IPI score, 58 patients (27.0%) were in the intermediate-high or high-risk ...
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.doi:10.1007/s00259-018-4093-1InternationalprognosticindexPET/CTPeripheralT-celllymphomaPrognosisTreatmentThe aim of this study was to establish a risk-stratification model integrating...
cyclophosphamide, doxorubicin, and prednisone(R-CHP)is indicated for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an International Prognostic Index score of 2 ...